Streetbeat News

BBRRF

Blueberries Medical Corp

http://www.blueberriesmed.com/

Industry

Medicinal and Botanical Manufacturing

Open

0.01

Mkt cap

3.8M

Volume

10K

High

0.01

P/E Ratio

-0.95

52-wk high

0.03

Low

0.01

Div yield

N/A

52-wk low

0.01

The article reports on the significant price movements of various cannabis-related stocks on January 30, 2024. Notable gainers include MedMen Enterprises, EVIO, Corbus Pharmaceuticals, and others, with MedMen and EVIO both closing up 9900.00% at $0.0001. On the losing side, Rhinomed led the declines with a 73.54% drop. The article lists both gainers and losers with their respective percentage changes and closing prices.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 9:30 pm

The article reports on the significant price movements of various marijuana stocks on January 29, 2024. Notable gainers include CordovaCann, Blueberries Medical, and 1933 Industries, with increases of 26.53%, 26.14%, and 15.88% respectively. Psychemedics, 4Front Ventures, and Canopy Growth also saw gains. On the losing side, EVIO plummeted by 99%, while Global Hemp Group and Corbus Pharmaceuticals experienced significant drops of 45.30% and 34.93%. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 9:30 pm

Cannabis stocks experienced significant volatility on January 26, 2024, with Corbus Pharmaceuticals leading the gainers with a 240.88% increase, while Blueberries Medical topped the losers with a 27.49% decline. Other notable movers included SOL Global Investments, C21 Investments, and OrganiGram Holdings with substantial gains, and 1933 Industries, Target Group, and Item 9 Labs with notable losses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 24, 2024. Notable gainers included Global Hemp Group, Target Group, and Item 9 Labs, with increases of 68.40%, 47.06%, and 14.29% respectively. Trulieve Cannabis and MJ Holdings also saw gains over 11%. Corbus Pharmaceuticals and Neptune Wellness Solutions were among the NASDAQ-listed gainers. Conversely, MedMen Enterprises and EVIO suffered dramatic losses, closing down 99.99% and 98.00%. Other notable losers included Khiron Life Sciences and Cara Therapeutics. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 9:30 pm

On January 22, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included Cansortium, Global Hemp Group, and Blueberries Medical, with increases of 27.27%, 25.00%, and 18.18% respectively. Urban-gro, OrganiGram Holdings, and Psychemedics also saw gains on NASDAQ. Conversely, AusCann Group Holdings, EVIO, and Maple Leaf Green World were among the biggest losers, with AusCann's shares plummeting by 59.42%. Corbus Pharmaceuticals and Eastside Distilling also experienced declines on NASDAQ.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 9:30 pm

The cannabis sector experienced bearish sentiment on January 18, 2024, with a mix of gainers and losers. Notable gainers included Genetic Technologies (GENE) and Urban-gro (UGRO), while significant losers were Aurora Cannabis (ACB), GrowGeneration (GRWG), OrganiGram Holdings (OGI), Tilray Brands (TLRY), Neptune Wellness Solutions (NEPT), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP), and Village Farms International (VFF).

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 16, 2024. Notable gainers include MedMen Enterprises, C21 Investments, and 22nd Century Group, with increases of 66.67%, 19.62%, and 14.92% respectively. On the losing side, Khiron Life Sciences and Global Hemp Group saw sharp declines of 49.64% and 44.60%. The article reflects the volatility in the cannabis market and may influence investor sentiment.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 9:30 pm

On January 11, 2024, several cannabis stocks experienced significant movements. Notable gainers included Heritage Cannabis Holding, Blueberries Medical, OrganiGram Holdings, and others, with increases ranging from 3.12% to 26.58%. Conversely, several companies faced declines, with Global Compliance leading the losers, followed by Rocky Mountain High, CLS Holdings USA, and others, with decreases ranging from 3.07% to 16.57%. The article lists the closing prices and percentage changes for each mentioned company.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 9:30 pm

The marijuana stock market saw significant movements on January 9, 2024, with a mix of gainers and losers. Notable gainers included AusCann Group Holdings, Rocky Mountain High, and Item 9 Labs with substantial percentage increases in their share prices. On the other hand, Australis Capital and Choom Holdings experienced dramatic declines, with Australis Capital shares closing down 100%. Other notable losers included Tilray Brands, Canopy Growth, and SNDL with significant percentage decreases. This market activity reflects the volatile nature of the marijuana industry stocks.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 9:30 pm

Marijuana stocks experienced significant movement on a recent Monday, with Australis Capital, EVIO, and several others posting substantial gains, while a few companies like Rocky Mountain High and MJ Holdings faced declines. The article lists the percentage changes and closing prices for the gainers and losers in the sector.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.